openPR Logo
Press release

ANCA Vasculitis Drug Market Top Leading Players with Strategies and Forecast 2028

03-23-2022 07:59 AM CET | Health & Medicine

Press release from: Orion Market Research

The global ANCA vasculitis drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). ANCA vasculitis is an autoimmune disease that affects the body's tiny blood vessels. Autoantibodies known as ANCAs, or Anti-Neutrophilic Cytoplasmic Autoantibodies, cause it. Neutrophils are a type of white blood cell that ANCAs target and attack. They go after the cytoplasm, which is a portion of neutrophils (the inside of the cell.) When autoantibodies (ANCAs) bind to neutrophils, the neutrophils target the body's tiny blood vessels. This is how vasculitis (blood vessel inflammation) occurs in this condition. As a result of ANCAs, neutrophils (a type of white blood cell) assault small blood arteries, causing them to swell and inflame. These ANCAs are not found in the majority of persons (autoantibodies that attack small blood vessels). Anti-B lymphocyte stimulatory monoclonal antibody belimumab is being tested in clinical studies for the treatment of ANCA-associated vasculitis GPA. Mepolizumab and Omalizumab are biologics that have been shown to be effective in the treatment of refractory asthma caused by EGPA.

To Request a Sample of our Report on ANCA Vasculitis Drug Market: https://www.omrglobal.com/request-sample/anca-vasculitis-drug-market

The ANCA vasculitis drugs market has shown significant growth in recent years owing to the new product launches by the market players. Some major key players in the market include Novartis International AG, and GlaxoSmithKline plc, among others. These market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2020, AVISE Vasculitis AAV, a new testing panel of individual analytes designed to provide physicians with rapid and reliable results in the assessment and monitoring of ANCA-associated vasculitis, was launched by Exagen Inc. an organisation dedicated to transforming the care continuum for patients suffering from autoimmune diseases (AAV).

Market Coverage

· The market number available for - 2021-2028

· Base year- 2021

· Forecast period- 2022-2028

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Novartis International AG, and GlaxoSmithKline plc, among others.

(Get 15% Discount on Buying this Report)

A full Report of ANCA Vasculitis Drug Market is Available @ https://www.omrglobal.com/industry-reports/anca-vasculitis-drug-market

Global ANCA Vasculitis Drug Market Report by Segment

By Type

· Belimumab

· Dalazatide

· CCX-168

· Others

By Application

· Clinic

· Hospital

· Others

Global ANCA Vasculitis Drug Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ANCA Vasculitis Drug Market Top Leading Players with Strategies and Forecast 2028 here

News-ID: 2584391 • Views: 484

More Releases from Orion Market Research

MRI Contrast Agent Market is Anticipated to Increase at a Stable CAGR over the F …
MRI contrast agent market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period. The rising frequency of chronic diseases affecting the brain, spine, and liver, as well as the occurrence of joint injuries in developing nations, however, the cost of MRI diagnostic is prohibitive, limiting the use of MRI techniques for diagnosis. As a result, the market's expansion may be slowed. The cost of MRI
Myoglobin Market Outlook 2029: Presents Market Insights & Depth Analysis
Myoglobin Market Outlook 2029: Presents Market Insights & Depth Analysis
Myoglobin market is anticipated to grow at a significant CAGR of 4.4% during the forecast period. The increased number of patients undergoing cardiac surgery, and growing knowledge of myoglobin's utility as an accurate indication of left ventricular wall thickening, drove demand for myoglobin reagents (LVWT) supporting the market. Myoglobin reagents are substances that are used to determine the amount of myoglobin in blood and urine samples. These tests are usually
MRSA Antibiotic Market Is Likely to Experience a Tremendous Growth by 2029
MRSA Antibiotic Market Is Likely to Experience a Tremendous Growth by 2029
The global MRSA antibiotic market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period. The major factors attributing to the growth of the MRSA drugs market are the rise in the global prevalence of MRSA infections and increasing private and public funding for R&D with regards to novel anti-MRSA drugs. For instance, in January 2020, Wockhardt announced regulatory approval to two antibiotics EMROK (IV) and
Telemetric Devices Market Share, Trends, Growth, Analysis and Forecast 2023-2030
Telemetric Devices Market Share, Trends, Growth, Analysis and Forecast 2023-2030
The global telemetric devices market is anticipated to grow at a CAGR of 16.0% during the forecast period (2023-2030). The high demand for telemetric devices globally, due to new product launches associated with telemetric devices is a key factor driving the growth of the global telemetric devices market. For instance, in June 2023, Apollo launched 5G-connected ambulance service in Kolkata. The custom-designed, 5G-connected ambulance is equipped with the latest medical

All 5 Releases


More Releases for ANCA

Grinding Machines Market: Junker Group, Kellenberger & Co. AG, ANCA Pty Ltd.
MarketResearchReports.Biz has recently announced the Latest industry research report on: "Global Grinding Machines Market" : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. This report presents the worldwide Grinding Machines market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities
ANCA Associated Diseases/Vasculitis Market Value Projected to Expand by 2025
Vasculitis is an autoimmune disease in which the body comes under attack from its own immune system, especially neutrophils, and in some cases it is also caused by reactions to medicines. It is a term for a group of rare diseases that are characterized by a condition that destroys blood vessels through inflammation. It can range from mild to life threatening and short term to long term. Vasculitis is caused
Olialia Chairperson ANCA VERMA conferred with BR Ambedkar Award ~ April 19, 2018
Olialia Chairperson Mrs. Anca Verma former Romanian Supermodel was conferred with Baba Sahib Dr.Bhim Rao Ambedkar Award on the 19th April 2018, by the Union Minister for Social Justice Mr. Thavar Chand Gehlot in New Delhi. Besides the Chief Guest, other Guests of Honour, such as Congress Leader Mrs. Usha Krishna Kumar, and other IAS and IPS officers and their wives were present to grace the occasion. The award was in recognition
ANCA Associated Diseases/Vasculitis Market Shares, Strategies and Forecast World …
Vasculitis is an autoimmune disease in which the body comes under attack from its own immune system, especially neutrophils, and in some cases it is also caused by reactions to medicines. It is a term for a group of rare diseases that are characterized by a condition that destroys blood vessels through inflammation. It can range from mild to life threatening and short term to long term. Vasculitis is caused
Anca Verma honored with the prestigious ‘Woman Entrepreneur of the Year 2018 …
New Delhi ~ 30th March 2018 Anca Verma, the wife of billionaire industrialist Abhishek Verma, recently was awarded the illustrious ‘Women Entrepreneur of the Year 2018’ Award at an event held in New Delhi. The 7th Asiad Literature Festival was organized to celebrate women’s achievements on the International Women’s Day, and promoting ‘I AM KHADI from Local to Global’ as well as ‘UdaanSkill’, a measure aimed at women empowerment. Organized on March
Olialia World Chairperson Mrs Anca Verma receives Women Empowerment Award
New Delhi 20th February 2018 Former Supermodel & Miss Universe Romania ANCA VERMA wife of billionaire philanthropist Abhishek Verma, was awarded at a power-packed function in New Delhi, an award for her outstanding work in the field of Women Empowerment in India. The function was organized by 'Women & Child Development Committee' in association with a NGO 'SheWings', at PHD Chamber of Commerce Auditorium in New Delhi, India. Union Minister for Women and